Literature DB >> 21349842

Altered expression of Ano1 variants in human diabetic gastroparesis.

Amelia Mazzone1, Cheryl E Bernard, Peter R Strege, Arthur Beyder, Luis J V Galietta, Pankaj J Pasricha, James L Rae, Henry P Parkman, David R Linden, Joseph H Szurszewski, Tamas Ördög, Simon J Gibbons, Gianrico Farrugia.   

Abstract

Diabetes affects many organs including the stomach. Altered number and function of interstitial cells of Cajal (ICC), the gastrointestinal pacemaker cells, underlie a number of gastrointestinal motility disorders, including diabetic gastroparesis. In the muscle layers, ICC selectively express Ano1, thought to underlie classical Ca(2+)-activated Cl(-) currents. Mice homozygous for Ano1 knock-out exhibit abnormal ICC function and motility. Several transcripts for Ano1 are generated by alternative splicing of four exons. Here, we report expression levels of transcripts encoded by alternative splicing of Ano1 gene in gastric muscles of patients with diabetic gastroparesis and nondiabetic control tissues. Expression of mRNA from two alternatively transcribed exons are significantly different between patients and controls. Furthermore, patients with diabetic gastroparesis express mRNA for a previously unknown variant of Ano1. The 5' end of this novel variant lacks exons 1 and 2 and part of exon 3. Expression of this variant in HEK cells produces a decreased density of Ca(2+)-activated Cl(-) currents that exhibit slower kinetics compared with the full-length Ano1. These results identify important changes in expression and splicing of Ano1 in patients with diabetic gastroparesis that alter the electrophysiological properties of the channel. Changes in Ano1 expression in ICC may directly contribute to diabetic gastroparesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21349842      PMCID: PMC3075685          DOI: 10.1074/jbc.M110.196089

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53.

Authors:  Stéphanie Courtois; Gerald Verhaegh; Sophie North; Maria-Gloria Luciani; Patrice Lassus; Ula Hibner; Moshe Oren; Pierre Hainaut
Journal:  Oncogene       Date:  2002-10-03       Impact factor: 9.867

Review 2.  Calcium-dependent chloride conductance in epithelia: is there a contribution by Bestrophin?

Authors:  Karl Kunzelmann; Vladimir M Milenkovic; Melanie Spitzner; René Barro Soria; Rainer Schreiber
Journal:  Pflugers Arch       Date:  2007-03-15       Impact factor: 3.657

Review 3.  Mechanosensitive ion channels in interstitial cells of Cajal and smooth muscle of the gastrointestinal tract.

Authors:  R E Kraichely; G Farrugia
Journal:  Neurogastroenterol Motil       Date:  2007-04       Impact factor: 3.598

4.  Regulation of TMEM16A chloride channel properties by alternative splicing.

Authors:  Loretta Ferrera; Antonella Caputo; Ifeoma Ubby; Erica Bussani; Olga Zegarra-Moran; Roberto Ravazzolo; Franco Pagani; Luis J V Galietta
Journal:  J Biol Chem       Date:  2009-10-09       Impact factor: 5.157

5.  Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes.

Authors:  C L He; E E Soffer; C D Ferris; R M Walsh; J H Szurszewski; G Farrugia
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

6.  The Ca-activated Cl channel and its control in rat olfactory receptor neurons.

Authors:  Johannes Reisert; Paul J Bauer; King-Wai Yau; Stephan Frings
Journal:  J Gen Physiol       Date:  2003-09       Impact factor: 4.086

7.  Regulation of interstitial cells of Cajal in the mouse gastric body by neuronal nitric oxide.

Authors:  K M Choi; S J Gibbons; J L Roeder; M S Lurken; J Zhu; M M Wouters; S M Miller; J H Szurszewski; G Farrugia
Journal:  Neurogastroenterol Motil       Date:  2007-07       Impact factor: 3.598

8.  Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract.

Authors:  Pedro J Gomez-Pinilla; Simon J Gibbons; Michael R Bardsley; Andrea Lorincz; Maria J Pozo; Pankaj J Pasricha; Matt Van de Rijn; Robert B West; Michael G Sarr; Michael L Kendrick; Robert R Cima; Eric J Dozois; David W Larson; Tamas Ordog; Gianrico Farrugia
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-16       Impact factor: 4.052

9.  Expression cloning of TMEM16A as a calcium-activated chloride channel subunit.

Authors:  Björn Christian Schroeder; Tong Cheng; Yuh Nung Jan; Lily Yeh Jan
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

10.  Changes in the gastric enteric nervous system and muscle: a case report on two patients with diabetic gastroparesis.

Authors:  Pankaj J Pasricha; Nonko D Pehlivanov; Guillermo Gomez; Harsha Vittal; Matthew S Lurken; Gianrico Farrugia
Journal:  BMC Gastroenterol       Date:  2008-05-30       Impact factor: 3.067

View more
  55 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXXV: calcium-activated chloride channels.

Authors:  Fen Huang; Xiuming Wong; Lily Y Jan
Journal:  Pharmacol Rev       Date:  2011-11-16       Impact factor: 25.468

2.  Targeting ion channels for the treatment of gastrointestinal motility disorders.

Authors:  Arthur Beyder; Gianrico Farrugia
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

Review 3.  Histologic changes in diabetic gastroparesis.

Authors:  Gianrico Farrugia
Journal:  Gastroenterol Clin North Am       Date:  2014-12-19       Impact factor: 3.806

4.  Molecular mechanism of TMEM16A regulation: role of CaMKII and PP1/PP2A.

Authors:  Ramon J Ayon; Matthew B Hawn; Joydeep Aoun; Michael Wiwchar; Abigail S Forrest; Fiona Cunningham; Cherie A Singer; Maria L Valencik; Iain A Greenwood; Normand Leblanc
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

5.  Inhibition of cell proliferation by a selective inhibitor of the Ca(2+)-activated Cl(-) channel, Ano1.

Authors:  Amelia Mazzone; Seth T Eisenman; Peter R Strege; Zhen Yao; Tamas Ordog; Simon J Gibbons; Gianrico Farrugia
Journal:  Biochem Biophys Res Commun       Date:  2012-09-17       Impact factor: 3.575

6.  TMEM16A is implicated in the regulation of coronary flow and is altered in hypertension.

Authors:  Henry R Askew Page; Thomas Dalsgaard; Samuel N Baldwin; Thomas A Jepps; Oleksandr Povstyan; Søren P Olesen; Iain A Greenwood
Journal:  Br J Pharmacol       Date:  2019-04-11       Impact factor: 8.739

Review 7.  Interstitial cells: regulators of smooth muscle function.

Authors:  Kenton M Sanders; Sean M Ward; Sang Don Koh
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

Review 8.  Gastroparesis: a turning point in understanding and treatment.

Authors:  Madhusudan Grover; Gianrico Farrugia; Vincenzo Stanghellini
Journal:  Gut       Date:  2019-09-28       Impact factor: 23.059

9.  Influence of intracellular Ca2+ and alternative splicing on the pharmacological profile of ANO1 channels.

Authors:  Tae Sik Sung; Kate O'Driscoll; Haifeng Zheng; Nicholas J Yapp; Normand Leblanc; Sang Don Koh; Kenton M Sanders
Journal:  Am J Physiol Cell Physiol       Date:  2016-07-13       Impact factor: 4.249

10.  Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension.

Authors:  Abigail S Forrest; Talia C Joyce; Marissa L Huebner; Ramon J Ayon; Michael Wiwchar; John Joyce; Natalie Freitas; Alison J Davis; Linda Ye; Dayue D Duan; Cherie A Singer; Maria L Valencik; Iain A Greenwood; Normand Leblanc
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-03       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.